Vector Space Biosciences

Vector Space Biosciences, Inc,(SBIO), parent company of Vectorspace AI (VAIX), along with its scientific collaborators, launch biological CubeSats for purpose of generating data related to microgravity and radiation. This data leads to the development of countermeasures against diseases associated to stressors connected to protecting and repairing the human body during spaceflight. This includes using a network of scientific data engineering pipelines for building targeted language models resulting in real-time datasets which power Artificial Intelligence (AI) operations in space biosciences, biotechnology and pharmaceutical development. Working with leading scientific labs in the areas of human aging, cancer, and nutrigenomics, our goal is to accelerate the process of new hypothesis generation and novel discoveries in space biosciences, including materials sciences in the area of nanotechnology and nanomedicines. Developing advanced large and small language modeling technologies, our platform is capable of producing more than different real-time datasets for the purpose of accelerating discoveries. Innovations in space biosciences result in products and services for all industries, including the financial markets, more importantly, new forms of precision medicine for all humankind.